12/23
09:02 am
bmra
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test [Yahoo! Finance]
Medium
Report
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test [Yahoo! Finance]
12/23
08:19 am
bmra
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
Medium
Report
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
12/11
09:13 am
bmra
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio [Yahoo! Finance]
Low
Report
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio [Yahoo! Finance]
12/11
08:08 am
bmra
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
Medium
Report
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
11/25
08:32 am
bmra
Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS [Yahoo! Finance]
Low
Report
Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS [Yahoo! Finance]
11/25
08:19 am
bmra
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
Medium
Report
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
11/6
08:19 am
bmra
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
Medium
Report
Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
10/16
08:19 am
bmra
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
Neutral
Report
Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
10/15
09:27 am
bmra
Biomerica Reports First Quarter Fiscal 2026 Financial Results
Medium
Report
Biomerica Reports First Quarter Fiscal 2026 Financial Results
10/8
08:45 am
bmra
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors [Yahoo! Finance]
Low
Report
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors [Yahoo! Finance]
10/8
08:19 am
bmra
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors
Low
Report
Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors